CTSO
Cytosorbents Corp
+0.02 (+0.35%)5.75USD2.4K成交股數361M市值–本益比(近四季)9.7股價營收比+0.2%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 7 · 120K · 3 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 269K · 0 |
| 近 180 天 淨額 | 269K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 3.8K | 6.00 | 23K | 101K | SEC |
| 2026-09-15 | 09-17 | Sobel Alan D. | Director | P 公開市場買進 | 100 | 6.01 | 601.00 | 9.9K | SEC |
| 2026-09-15 | 09-17 | Sobel Alan D. | Director | P 公開市場買進 | 500 | 6.05 | 3K | 9.8K | SEC |
| 2026-09-15 | 09-17 | Sobel Alan D. | Director | P 公開市場買進 | 1.9K | 6.12 | 12K | 9.3K | SEC |
| 2026-09-14 | 09-17 | Capponi Vincent | President and COO | P 公開市場買進 | 1.8K | 6.07 | 11K | 40.1K | SEC |
| 2026-09-14 | 09-17 | Capponi Vincent | President and COO | P 公開市場買進 | 273 | 5.90 | 2K | 40.4K | SEC |
| 2026-09-04 | 09-09 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 200K | 0.35 | 70K | 1.9M | SEC |
| 2026-06-15 | 06-16 | MARIANI PETER J | Chief Financial Officer | P 公開市場買進 | 100K | 0.44 | 44K | 638K | SEC |
| 2026-06-15 | 06-15 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 10.3K | 0.43 | 4K | 1.7M | SEC |
| 2026-06-12 | 06-15 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 251K | 0.40 | 100K | 1.7M | SEC |
| 2025-11-18 | 11-20 | Chan Phillip P. | Chief Executive Officer | A 獲配股票 | 100K | 0.64 | 64K | 1.5M | SEC |
| 2025-08-08 | 08-08 | Chan Phillip P. | Chief Executive Officer | A 獲配股票 | 106K | – | – | 1.4M | SEC |
| 2025-08-08 | 08-08 | MARIANI PETER J | Chief Financial Officer | A 獲配股票 | 71.5K | – | – | 538K | SEC |
| 2025-08-08 | 08-08 | Capponi Vincent | President and COO | A 獲配股票 | 89.1K | – | – | 766K | SEC |
| 2025-08-08 | 08-08 | Deliargyris Efthymios | Chief Medical Officer | A 獲配股票 | 70.0K | – | – | 473K | SEC |
| 2025-01-17 | 01-22 | Capponi Vincent | President and COO | X 選擇權履約 | 31.8K | 1.00 | 32K | 665K | SEC |
| 2025-01-17 | 01-22 | MARIANI PETER J | Chief Financial Officer | X 選擇權履約 | 32.6K | 1.00 | 33K | 434K | SEC |
| 2025-01-17 | 01-22 | Deliargyris Efthymios | Chief Medical Officer | X 選擇權履約 | 16.2K | 1.00 | 16K | 403K | SEC |
| 2025-01-17 | 01-22 | BATOR MICHAEL G. | Director | X 選擇權履約 | 15.9K | 1.00 | 16K | 141K | SEC |
| 2025-01-17 | 01-22 | Sobel Alan D. | Director | X 選擇權履約 | 21.9K | 1.00 | 22K | 124K | SEC |
| 2025-01-17 | 01-22 | Chan Phillip P. | Chief Executive Officer | X 選擇權履約 | 90.8K | 1.00 | 91K | 1.2M | SEC |
| 2024-12-13 | 12-16 | MARIANI PETER J | Chief Financial Officer | P 公開市場買進 | 20.0K | 0.96 | 19K | 401K | SEC |
| 2024-12-12 | 12-13 | MARIANI PETER J | Chief Financial Officer | P 公開市場買進 | 20.0K | 0.89 | 18K | 381K | SEC |
| 2024-12-11 | 12-13 | MARIANI PETER J | Chief Financial Officer | P 公開市場買進 | 11.4K | 0.89 | 10K | 361K | SEC |
| 2024-08-14 | 08-16 | MARIANI PETER J | Chief Financial Officer | A 獲配股票 | 110K | – | – | 110K | SEC |
| 2024-08-14 | 08-16 | MARIANI PETER J | Chief Financial Officer | A 獲配股票 | 65.0K | – | – | 175K | SEC |
| 2024-08-14 | 08-16 | MARIANI PETER J | Chief Financial Officer | A 獲配股票 | 175K | – | – | 350K | SEC |
| 2024-04-02 | 04-04 | Deliargyris Efthymios | Chief Medical Officer | A 獲配股票 | 61.0K | – | – | 409K | SEC |
| 2024-04-02 | 04-04 | BLOCH KATHLEEN P. | Chief Financial Officer | A 獲配股票 | 65.0K | – | – | 533K | SEC |
| 2024-04-02 | 04-04 | Capponi Vincent | President and COO | A 獲配股票 | 81.0K | – | – | 665K | SEC |
| 2024-04-02 | 04-04 | Chan Phillip P. | Chief Executive Officer | A 獲配股票 | 96.0K | – | – | 1.2M | SEC |
| 2023-12-13 | 12-15 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 75.2K | 1.33 | 100K | 1.1M | SEC |
| 2023-12-13 | 12-15 | Kim Jiny | Director | P 公開市場買進 | 7.5K | 1.33 | 10K | 77.8K | SEC |
| 2023-12-13 | 12-15 | Deliargyris Efthymios | Chief Medical Officer | P 公開市場買進 | 22.6K | 1.33 | 30K | 348K | SEC |
| 2023-12-13 | 12-15 | BATOR MICHAEL G. | Director | P 公開市場買進 | 37.6K | 1.33 | 50K | 125K | SEC |
| 2023-12-13 | 12-15 | Capponi Vincent | President & COO | P 公開市場買進 | 18.8K | 1.33 | 25K | 584K | SEC |
| 2023-12-13 | 12-15 | BLOCH KATHLEEN P. | Chief Financial Officer | P 公開市場買進 | 37.6K | 1.33 | 50K | 468K | SEC |
| 2023-12-13 | 12-15 | Sobel Alan D. | Director | P 公開市場買進 | 22.6K | 1.33 | 30K | 102K | SEC |
| 2023-12-13 | 12-15 | Jones Edward Raymond | Director | P 公開市場買進 | 7.5K | 1.33 | 10K | 88.8K | SEC |
| 2023-09-18 | 09-20 | BLOCH KATHLEEN P. | Chief Financial Officer | A 獲配股票 | 45.0K | – | – | 442K | SEC |
| 2023-08-07 | 08-08 | BATOR MICHAEL G. | Director | P 公開市場買進 | 1.0K | 3.20 | 3K | 86.8K | SEC |
| 2023-08-07 | 08-08 | BATOR MICHAEL G. | Director | P 公開市場買進 | 1.0K | 3.15 | 3K | 87.8K | SEC |
| 2023-08-04 | 08-08 | BATOR MICHAEL G. | Director | P 公開市場買進 | 1.0K | 3.23 | 3K | 85.8K | SEC |
| 2023-07-07 | 07-11 | Chan Phillip P. | Chief Executive Officer | A 獲配股票 | 87.0K | – | – | 1.0M | SEC |
| 2023-07-07 | 07-11 | Capponi Vincent | President & COO | A 獲配股票 | 73.0K | – | – | 576K | SEC |
| 2023-07-07 | 07-11 | Deliargyris Efthymios | Chief Medical Officer | A 獲配股票 | 55.0K | – | – | 332K | SEC |
| 2023-05-25 | 05-30 | BLOCH KATHLEEN P. | Interim CFO | P 公開市場買進 | 1.1K | 2.85 | 3K | 44.8K | SEC |
| 2023-05-25 | 05-30 | BLOCH KATHLEEN P. | Interim CFO | P 公開市場買進 | 1.1K | 2.85 | 3K | 47.0K | SEC |
| 2023-05-25 | 05-30 | BLOCH KATHLEEN P. | Interim CFO | P 公開市場買進 | 1.1K | 2.84 | 3K | 45.9K | SEC |
| 2023-05-10 | 05-12 | BLOCH KATHLEEN P. | Interim CFO | P 公開市場買進 | 2.0K | 3.13 | 6K | 40.7K | SEC |
| 2023-05-10 | 05-12 | BLOCH KATHLEEN P. | Interim CFO | P 公開市場買進 | 5.0K | 3.06 | 15K | 38.7K | SEC |
| 2023-05-10 | 05-12 | BLOCH KATHLEEN P. | Interim CFO | P 公開市場買進 | 3.0K | 3.17 | 10K | 43.7K | SEC |
| 2023-04-04 | 04-05 | Capponi Vincent | See Remarks | M 選擇權執行 | 10.0K | 2.88 | 29K | 512K | SEC |
| 2023-04-03 | 04-05 | Chan Phillip P. | Chief Executive Officer | M 選擇權執行 | 30.5K | 2.88 | 88K | 928K | SEC |
| 2023-02-27 | 03-01 | Sobel Alan D. | Director | G 贈與 | 2.0K | – | – | 0 | SEC |
| 2023-02-27 | 03-01 | Sobel Alan D. | Director | G 贈與 | 2.0K | – | – | 81.3K | SEC |
| 2023-02-06 | 02-08 | Kraus Al | Director | M 選擇權執行 | 12.0K | 2.65 | 32K | 142K | SEC |
| 2022-12-08 | 12-09 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 5.9K | 1.26 | 7K | 897K | SEC |
| 2022-12-07 | 12-08 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 9.8K | 1.26 | 12K | 891K | SEC |
| 2022-12-06 | 12-08 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 14.3K | 1.26 | 18K | 882K | SEC |
| 2022-09-08 | 09-12 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 35.0K | 1.70 | 60K | 867K | SEC |
| 2022-08-25 | 08-26 | Director | P 公開市場買進 | 1.0K | 1.91 | 2K | 70.3K | SEC | |
| 2022-08-10 | 08-12 | BLOCH KATHLEEN P. | Chief Financial Officer | A 獲配股票 | 55.5K | – | – | 405K | SEC |
| 2022-08-10 | 08-12 | Deliargyris Efthymios | Chief Medical Officer | A 獲配股票 | 55.0K | – | – | 228K | SEC |
| 2022-08-10 | 08-12 | Chan Phillip P. | Chief Executive Officer | A 獲配股票 | 79.0K | – | – | 845K | SEC |
| 2022-08-10 | 08-12 | Deliargyris Efthymios | Chief Medical Officer | A 獲配股票 | 52.0K | – | – | 283K | SEC |
| 2022-08-10 | 08-12 | Capponi Vincent | President and COO | A 獲配股票 | 69.0K | – | – | 513K | SEC |
| 2022-06-21 | 06-22 | Capponi Vincent | President and COO | P 公開市場買進 | 2.0K | 1.80 | 4K | 444K | SEC |
| 2022-06-16 | 06-21 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 2.2K | 1.85 | 4K | 768K | SEC |
| 2022-06-16 | 06-21 | Capponi Vincent | See Remarks | P 公開市場買進 | 3.0K | 2.00 | 6K | 442K | SEC |
| 2022-06-09 | 06-10 | Chan Phillip P. | Chief Executive Officer | P 公開市場買進 | 16.0K | 2.17 | 35K | 766K | SEC |
| 2022-06-06 | 06-06 | BLOCH KATHLEEN P. | Chief Financial Officer | P 公開市場買進 | 8.7K | 1.90 | 17K | 33.7K | SEC |
| 2022-05-23 | 05-25 | Capponi Vincent | President and COO | P 公開市場買進 | 3.1K | 2.03 | 6K | 439K | SEC |
| 2022-05-23 | 05-25 | Capponi Vincent | President and COO | P 公開市場買進 | 299 | 2.03 | 606.97 | 435K | SEC |
| 2022-05-23 | 05-25 | Capponi Vincent | President and COO | P 公開市場買進 | 1.6K | 2.04 | 3K | 435K | SEC |
| 2022-05-18 | 05-19 | BATOR MICHAEL G. | Director | P 公開市場買進 | 2.0K | 2.20 | 4K | 83.8K | SEC |
| 2022-05-18 | 05-19 | BATOR MICHAEL G. | Director | P 公開市場買進 | 2.0K | 2.20 | 4K | 81.8K | SEC |
| 2022-05-18 | 05-19 | BATOR MICHAEL G. | Director | P 公開市場買進 | 2.0K | 2.20 | 4K | 79.8K | SEC |
| 2022-05-18 | 05-19 | BATOR MICHAEL G. | Director | P 公開市場買進 | 2.0K | 2.18 | 4K | 77.8K | SEC |
| 2022-05-18 | 05-19 | BATOR MICHAEL G. | Director | P 公開市場買進 | 2.0K | 2.18 | 4K | 75.8K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| AVENIR CORP | 5.2M | 1.9M | −26.6K (-1%) | 減碼 |
| NEUBERGER BERMAN GROUP LLC | 2.0M | 741K | +286K (+17%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | 716K | +34.1K (+2%) | 加碼 |
| CM Management, LLC | 1.5M | 552K | 不變 | 持平 |
| Skylands Capital, LLC | 1.2M | 453K | −496K (-29%) | 減碼 |
| BlackRock, Inc. | 627K | 235K | −156K (-20%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 602K | 225K | −105K (-15%) | 減碼 |
| Sargent Investment Group, LLC | 556K | 208K | +5.9K (+1%) | 加碼 |
| Pathstone Holdings, LLC | 500K | 187K | −45 (-0%) | 減碼 |
| VANGUARD FIDUCIARY TRUST CO | 316K | 118K | +2.3K (+1%) | 加碼 |
| CIBC Bancorp USA Inc. | 173K | 65K | 不變 | 持平 |
| STATE STREET CORP | 159K | 60K | 不變 | 持平 |
| OSAIC HOLDINGS, INC. | 135K | 50K | +4.4K (+3%) | 加碼 |
| UBS Group AG | 131K | 49K | +15.8K (+14%) | 加碼 |
| NORTHERN TRUST CORP | 112K | 42K | +19.1K (+21%) | 加碼 |
| RAYMOND JAMES FINANCIAL INC | 108K | 40K | −140 (-0%) | 減碼 |
| NWF Advisory Services Inc. | 104K | 39K | 不變 | 持平 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 100K | 37K | −700 (-1%) | 減碼 |
| MORGAN STANLEY | 91.3K | 34K | −8.8K (-9%) | 減碼 |
| Key Client Fiduciary Advisors, LLC | 78.5K | 29K | 不變 | 持平 |
| XTX Topco Ltd | 54.3K | 20K | +18.7K (+53%) | 加碼 |
| JANE STREET GROUP, LLC | 52.2K | 20K | 新進 | 新進 |
| LPL Financial LLC | 50.1K | 19K | +26.9K (+116%) | 加碼 |
| STIFEL FINANCIAL CORP | 48.0K | 18K | 不變 | 持平 |
| BANK OF AMERICA CORP /DE/ | 38.7K | 14K | −437 (-1%) | 減碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 51 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 8 / 7 / 9 / 9 |
| 機構合計持股 · 佔流通股 | 16.1M · 25.7% |
| 合計季末市值 | 6.0M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.3M |
|---|---|
| 與上期比 | +6.9% |
| 佔流通股數 | 3.67% |
| 日均成交量 | 126K |
| 回補天數 | 18.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.3M | +6.9% | 3.67% | 126K | 18.3 |
| 2026-08-14 | 2.2M | +0.7% | 3.43% | 72.2K | 29.9 |
| 2026-07-31 | 2.1M | +1.1% | 3.41% | 55.9K | 38.3 |
| 2026-07-15 | 2.1M | +1.9% | 3.37% | 78.9K | 26.9 |
| 2026-06-30 | 2.1M | -0.4% | 3.31% | 333K | 6.2 |
| 2026-06-15 | 2.1M | +0.8% | 3.32% | 264K | 7.9 |
| 2026-05-29 | 2.1M | +0.7% | 3.30% | 112K | 18.5 |
| 2026-05-15 | 2.1M | +0.7% | 3.27% | 99.8K | 20.6 |
| 2026-04-30 | 2.0M | -0.1% | 3.25% | 43.3K | 47.2 |
| 2026-04-15 | 2.0M | +1.2% | 3.25% | 84.0K | 24.3 |
| 2026-03-31 | 2.0M | +0.1% | 3.22% | 135K | 15.0 |
| 2026-03-13 | 2.0M | +0.9% | 3.21% | 73.1K | 27.6 |
| 2026-02-27 | 2.0M | -1.9% | 3.18% | 51.1K | 39.1 |
| 2026-02-13 | 2.0M | +0.1% | 3.24% | 77.5K | 26.3 |
| 2026-01-30 | 2.0M | +2.5% | 3.24% | 78.9K | 25.8 |
| 2026-01-15 | 2.0M | -0.8% | 3.16% | 68.8K | 28.9 |
| 2025-12-31 | 2.0M | +0.3% | 3.19% | 151K | 13.2 |
| 2025-12-15 | 2.0M | -0.9% | 3.18% | 121K | 16.4 |
| 2025-11-28 | 2.0M | +3.1% | 3.20% | 124K | 16.2 |
| 2025-11-14 | 2.0M | +24.6% | 3.11% | 143K | 13.7 |
| 2025-10-31 | 1.6M | +18.9% | 2.49% | 79.2K | 19.8 |
| 2025-10-15 | 1.3M | -1.9% | 2.10% | 71.3K | 18.5 |
| 2025-09-30 | 1.3M | -0.5% | 2.14% | 86.4K | 15.5 |
| 2025-09-15 | 1.3M | -2.8% | 2.15% | 58.5K | 23.1 |
| 2025-08-29 | 1.4M | -6.9% | 2.21% | 186K | 7.5 |
| 2025-08-15 | 1.5M | +8.9% | 2.37% | 523K | 2.9 |